{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-098971","form_type":"8-K","ticker":"GRDX","cik":"0001604191","company_name":"GridAI Technologies Corp.","filed_at":"2024-09-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.738025+00:00","generated_at":"2026-05-31T05:26:38.745596+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Entero Therapeutics receives Nasdaq bid price deficiency notice; 180 days to cure","bullets":["Nasdaq notified Entero on Sept 6, 2024 that common stock failed minimum $1.00 bid price for 30 consecutive business days.","Company has until March 5, 2025 to regain compliance by closing at $1.00 for 10 consecutive business days.","If not compliant, Nasdaq may grant second 180-day period if other listing standards met; otherwise delisting possible.","Company intends to monitor bid price and seek compliance; no assurance of success."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-098971","json":"https://secwatch.observer/filing/0001104659-24-098971.json","markdown":"https://secwatch.observer/filing/0001104659-24-098971.md","text":"https://secwatch.observer/filing/0001104659-24-098971.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924098971/0001104659-24-098971-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1604191/000110465924098971/tm2423832d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T05:26:38.745596+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}